This is a type of non-cancerous (benign) tumor that grows in the brain. It's made up of cells that are similar to nerve cells. While usually harmless, it can sometimes cause problems like seizures or headaches.
Every report comes from a Lived member, sent anonymously.
Have you had Craniotomy for Neurocytoma?
A neurocytoma is a rare brain tumor made of cells that resemble developing nerve cells. Most are central neurocytomas, which grow inside the ventricles, the fluid-filled spaces deep in the brain. They usually sit in one of the two lateral ventricles, attached to the thin wall (the septum pellucidum) that divides them. Neurocytomas make up well under 1% of brain tumors and are most often found in young adults, typically in their 20s and 30s. Neurocytomas usually grow slowly, and doctors generally consider them benign. The World Health Organization classifies them as grade 2, which reflects that they can grow back after treatment. Most of their effects come from where they sit. As the tumor enlarges, it can block the openings that let cerebrospinal fluid, the fluid that cushions the brain, drain out of the ventricles. The trapped fluid builds up, a condition called hydrocephalus, and raises pressure inside the skull. That pressure is what causes the typical headaches, nausea, vomiting and blurred vision. Less often, a neurocytoma grows outside the ventricles, in brain tissue or the spinal cord. These extraventricular neurocytomas look somewhat different under the microscope and can also cause weakness or numbness in the limbs.
Researchers don't know what causes neurocytomas. They appear to arise from immature cells that would normally develop into neurons, but no lifestyle habit, exposure or other risk factor has been shown to bring one on. Men and women are affected about equally. Some studies report more cases in Korea, India and Japan, possibly reflecting genetic differences, but this has not been established. Because the cause is unknown, there is no known way to prevent a neurocytoma or to screen for one.
Most neurocytomas are found when someone has a brain scan for headaches, vision changes or other signs of raised pressure. An MRI (magnetic resonance imaging) scan typically shows a well-defined mass inside a ventricle, often with the ventricles enlarged by trapped fluid. A CT (computed tomography) scan frequently shows specks of calcium in the tumor, which are present in up to half of cases. Imaging can strongly suggest a neurocytoma, but it cannot reliably tell it apart from other tumors that grow in the same place, such as ependymomas or oligodendrogliomas. The diagnosis is confirmed when a pathologist examines tissue removed during surgery, using stains that detect nerve-cell proteins such as synaptophysin. The pathologist also measures how many tumor cells are actively dividing, reported as a Ki-67 index, the percentage of cells that carry a marker of cell division. In several large studies, tumors with a value above about 3% were more likely to come back. These are often called atypical neurocytomas, and the result can shape decisions about radiation and how closely to follow the tumor afterward.
Surgery is the main treatment. A neurosurgeon aims to remove the whole tumor when that can be done safely, because complete removal gives the best long-term control. In pooled studies, about 99% of people were alive five years after complete removal, compared with about 86% after partial removal. Complete removal is not always possible, because the tumor sits deep in the brain near structures involved in memory, movement and vision; studies report it in roughly 30 to 50% of people. When it isn't, the surgeon removes as much as is safe. Surgery often relieves the fluid blockage, but some people still need a shunt (a thin tube that drains excess fluid to another part of the body) or an endoscopic third ventriculostomy, a procedure that opens a new drainage path inside the brain. Radiation is generally reserved for tumor left behind after surgery, a tumor that comes back, a tumor that cannot be operated on, or an atypical tumor. It can be given as conventional radiotherapy, in many smaller doses, or as stereotactic radiosurgery (such as Gamma Knife), which focuses a high dose on the tumor in one to five sessions. In observational studies, adding radiation after partial removal clearly lowered the chance of regrowth, and radiosurgery controlled the treated tumor in about 9 in 10 people. The trade-off is possible injury to surrounding brain, which can appear long after treatment as memory, thinking or movement problems. Whether radiation adds anything after complete removal is still debated. Chemotherapy is not a standard treatment. It has occasionally been used for tumors that keep returning or cannot be treated another way, but the evidence comes only from individual case reports. Because neurocytomas are rare, all treatment evidence comes from case series rather than trials, so care is best planned with an experienced neurosurgery and neuro-oncology team.
The outlook for most people with a central neurocytoma is good, particularly after complete removal. Recovery from surgery depends on the tumor's position and the surgical route. Some people have problems with memory, speech or strength afterward; in many cases these improve over the following months. Headaches and vision symptoms caused by fluid pressure usually ease once drainage is restored. The tumor can come back, sometimes more than a decade later, and the risk is higher after partial removal and with atypical tumors. For that reason, follow-up involves MRI scans over many years, with treatment considered again if the tumor regrows. Fluid problems can also persist or return after surgery even when the tumor is gone. Someone who has a shunt will need it checked over time, because shunts can block or fail and may need to be repaired or replaced.
See a doctor about headaches that keep returning or slowly worsen, especially with nausea, blurred vision, memory problems or unsteadiness. After treatment, tell your care team if any of your original symptoms come back, since that can signal regrowth or a new fluid blockage. If you have a shunt, contact your care team right away for headache with vomiting, double vision, or redness or tenderness along the shunt, which can mean it is not working. Get emergency care for a sudden, severe headache with repeated vomiting, drowsiness or difficulty waking, new confusion, or a seizure. A blocked fluid pathway or bleeding into the ventricle can raise pressure inside the skull quickly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Neurocytoma is like, what's helped you, or ask the community a question.